《業績》巨星傳奇(06683.HK)中期純利1,027萬人民幣跌58.9% 不派息
巨星傳奇(06683.HK)公佈6月止六個月中期業績,收入3.55億人民幣(下同),按年增加33%,其中,新消費業務收入2.11億元,增加91.5%;毛利1.56億元,上升16.3%。錄得純利1,027萬元,倒退58.9%,主要受香港上市股本證券投資公平值虧損1,950萬元影響;每股盈利1分。不派息。
下半年,集團擬專注於以「周同學」及其家族以及其他明星IP爲主題的自主研發IP相關產品的進一步開發。此外,正考慮在廣州開設首家以「周同學」爲主題的「黑標」店,提供一系列與集團明星IP相關的高端產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.